OCM
ZURA icon

Oaktree Capital Management’s Zura Bio ZURA Stock Holding History

Oaktree Capital Management’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-150,000
Closed -$1.47M – 381
2021
Q3 		$1.47M Buy
+150,000
New +$1.47M 0.02% 223

Other funds holding ZURA

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
SCC
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

Oaktree Capital Management's ZURA Position: Q4 2021 in Review

Oaktree Capital Management sold out of Zura Bio (ZURA) in Q4 2021, closing a stake of 150,000 shares — an estimated $1.47M sold.

Oaktree Capital Management first reported a position in ZURA in Q3 2021 and held it in 1 quarter. The position peaked at $1.47M in Q3 2021. 25 funds tracked by Wall St. Rank hold ZURA as of Q4 2021.

  • Oaktree Capital Management reported no remaining Zura Bio position as of Q4 2021 after selling out during the quarter.
  • Oaktree Capital Management sold 150,000 Zura Bio shares in Q4 2021, an estimated $1.47M.
  • Oaktree Capital Management first reported a position in Zura Bio in Q3 2021 and held it in 1 quarter.
  • Oaktree Capital Management's Zura Bio position peaked at $1.47M in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Zura Bio as of Q4 2021.

Based on Oaktree Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.